With the incoming implementation of the EU Clinical Trial Regulation 536/2014 in December 2021, Parexel, an end-to-end innovative therapeutics solutions provider, has announced the launch of their Regulatory Submissions Hub Service for their life science and biopharmaceutical customers. The Submissions Hub will streamline assessment and supervision processes for EU clinical trials, providing customers with ease of use and navigation. The customizable and customer-centric hub will make it possible for the EU to remain compliant when submitting their clinical trials in coordination with the new governance.

Read more here.

More on: